相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Targeting HMGB1-mediated autophagy as a novel therapeutic strategy for osteosarcoma
Jun Huang et al.
AUTOPHAGY (2012)
Mechanism of anthracycline-mediated down-regulation of GATA4 in the heart
Ah-Mee Park et al.
CARDIOVASCULAR RESEARCH (2011)
Mechanisms and management of doxorubicin cardiotoxicity
Y. Shi et al.
HERZ (2011)
Dextran-g-PEI nanoparticles as a carrier for co-delivery of adriamycin and plasmid into osteosarcoma cells
Kuo Sun et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2011)
Activation of AMP-Activated Protein Kinase is Involved in Vincristine-Induced Cell Apoptosis in B16 Melanoma Cell
Min-Bin Chen et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2011)
The performance of doxorubicin encapsulated in chitosan-dextran sulphate microparticles in an osteosarcoma model
Mei L. Tan et al.
BIOMATERIALS (2010)
Doxorubicin Cardiomyopathy
Kanu Chatterjee et al.
CARDIOLOGY (2010)
Pharmacogenetics of Target Genes Across Doxorubicin Disposition Pathway: A Review
Suman Lal et al.
CURRENT DRUG METABOLISM (2010)
Mitochondrial DNA is a direct target of anti-cancer anthracycline drugs
Neil Ashley et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
A chitosan-dipotassium orthophosphate hydrogel for the delivery of Doxorubicin in the treatment of osteosarcoma
Hang T. Ta et al.
BIOMATERIALS (2009)
Doxorubicin: The Good, the Bad and the Ugly Effect
Cristina Carvalho et al.
CURRENT MEDICINAL CHEMISTRY (2009)
Chitosan-dibasic orthophosphate hydrogel: A potential drug delivery system
Hang T. Ta et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2009)
Compound K Induces Apoptosis via CAMK-IV/AMPK Pathways in HT-29 Colon Cancer Cells
Do Yeon Kim et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2009)
ABCB8 Mediates Doxorubicin Resistance in Melanoma Cells by Protecting the Mitochondrial Genome
Aaron M. Elliott et al.
MOLECULAR CANCER RESEARCH (2009)
The AMPK agonist AICAR inhibits the growth of EGFRvIII-expressing glioblastomas by inhibiting lipogenesis
Deliang Guo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Cognitive effects of chemotherapy in post-menopausal breast cancer patients 1 year after treatment
Barbara Collins et al.
PSYCHO-ONCOLOGY (2009)
Inhibition of Arachidonic Acid and Iron-Induced Mitochondrial Dysfunction and Apoptosis by Oltipraz and Novel 1,2-Dithiole-3-thione Congeners
Sang Mi Shin et al.
MOLECULAR PHARMACOLOGY (2009)
ERKs/p53 signal transduction pathway is involved in doxorubicin-induced apoptosis in H9c2 cells and cardiomyocytes
Jiahao Liu et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2008)
AM251 suppresses the viability of HepG2 cells through the AMPK (AMP-activated protein kinase)-JNK (c-Jun N-terminal kinase)-ATF3 (activating transcription factor 3) pathway
Yun Mi Lee et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
A role for ceramide in driving cancer cell resistance to doxorubicin
Yong-Yu Liu et al.
FASEB JOURNAL (2008)
AMP-activated Protein Kinase Contributes to UV- and H2O2-induced Apoptosis in Human Skin Keratinocytes
Cong Cao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
AMPK phosphorylation of raptor mediates a metabolic checkpoint
Dana M. Gwinn et al.
MOLECULAR CELL (2008)
Molecular origins of cancer: Oncogenes and cancer
Carlo M. Croce
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Preliminary results of a longitudinal study of changes in cognitive function in breast cancer patients undergoing chemotherapy with doxorubicin and cyclophosphamide
Catherine E. Jansen et al.
PSYCHO-ONCOLOGY (2008)
Activation of AMP-activated protein kinase induces p53-dependent apoptotic cell death in response to energetic stress
Rintaro Okoshi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Toll-like receptor 2 modulates left ventricular function following ischemia-reperfusion injury
Yasushi Sakata et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2007)
Quality of life analyses in a clinical trial of DPPE (tesmilifene) plus doxorubicin versus doxorubicin in patients with advanced or metastatic breast cancer: NCICCTG trial MA.19
Jianhua Liu et al.
BREAST CANCER RESEARCH AND TREATMENT (2006)
An ancestral haplotype defines susceptibility to doxorubicin nephropathy in the laboratory mouse
Zongyu Zheng et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
Adriamycin-induced, TNF-α-mediated central nervous system toxicity
Jitanjong Tangpong et al.
NEUROBIOLOGY OF DISEASE (2006)
AMP-activated protein kinase protects cardiomyocytes against hypoxic injury through attenuation of endoplasmic reticulum stress
K Terai et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
AMP-activated protein kinase induces a p53-dependent metabolic checkpoint
RG Jones et al.
MOLECULAR CELL (2005)
Oncogenes as novel targets for cancer therapy (Part III) Transcription factors
Z Zhang et al.
AMERICAN JOURNAL OF PHARMACOGENOMICS (2005)
Individual differences in renal ACE activity in healthy rats predict susceptibility to adriamycin-induced renal damage
M Rook et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2005)
The tumor suppressor LKB1 kinase directly activates AMP-activated kinase and regulates apoptosis in response to energy stress
RJ Shaw et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Pifithrin-α protects against doxorubicin-induced apoptosis and acute cardiotoxicity in mice
XW Liu et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2004)
AMP-activated protein kinase activators can inhibit the growth of prostate cancer cells by multiple mechanisms
XQ Xiang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
The hepatic pharmacokinetics of doxorubicin and liposomal doxorubicin
SN Hilmer et al.
DRUG METABOLISM AND DISPOSITION (2004)
Pegylated liposomal doxorubicin: Proof of principle using preclinical animal models and pharmacokinetic studies
DM Vail et al.
SEMINARS IN ONCOLOGY (2004)
Anthracyclines: Molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity
G Minotti et al.
PHARMACOLOGICAL REVIEWS (2004)
Low-molecular-weight polyethylenimine as a non-viral vector for DNA delivery: comparison of physicochemical properties, transfection efficiency and in vivo distribution with high-molecular-weight polyethylenimine
K Kunath et al.
JOURNAL OF CONTROLLED RELEASE (2003)
AMP-activated protein kinase can induce apoptosis of insulin-producing MIN6 cells through stimulation of c-Jun-N-terminal kinase
BA Kefas et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2003)
Anthracycline-induced suppression of GATA-4 transcription factor: Implication in the regulation of cardiac myocyte apoptosis
Y Kim et al.
MOLECULAR PHARMACOLOGY (2003)
5 '-aminoimidazole-4-carboxamide riboside induces apoptosis in human neuroblastoma cells
M Garcia-Gil et al.
NEUROSCIENCE (2003)
Pharmacokinetics of pegylated liposomal doxorubicin - Review of animal and human studies
A Gabizon et al.
CLINICAL PHARMACOKINETICS (2003)
Mechanisms of disease: Rules for making human tumor cells.
WC Hahn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Global gene expression changes during neoadjuvant chemotherapy for human breast cancer
TA Buchholz et al.
CANCER JOURNAL (2002)
Characterization of a novel metabolic strategy used by drug-resistant tumor cells
ME Harper et al.
FASEB JOURNAL (2002)
Sustained activation of AMP-activated protein kinase induces c-Jun N-terminal kinase activation and apoptosis in liver cells
D Meisse et al.
FEBS LETTERS (2002)
Photo-induced cytotoxicity of malonic acid [C60]fullerene derivatives and its mechanism
XL Yang et al.
TOXICOLOGY IN VITRO (2002)
Pharmacokinetic-pharmacodynamic relationships of the anthracycline anticancer drugs
R Danesi et al.
CLINICAL PHARMACOKINETICS (2002)
Cell cycle regulation via p53 phosphorylation by a 5′-AMP activated protein kinase activator, 5-aminoimidazole-4-carboxamide-1-β-D-ribofuranoside, in a human hepatocellular carcinoma cell line
K Imamura et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2001)
Tumour targeted delivery of encapsulated dextran-doxorubicin conjugate using chitosan nanoparticles as carrier
S Mitra et al.
JOURNAL OF CONTROLLED RELEASE (2001)
Liposome application: problems and prospects
Y Barenholz
CURRENT OPINION IN COLLOID & INTERFACE SCIENCE (2001)
Progressive adriamycin nephropathy in mice: Sequence of histologic and immunohistochemical events
Y Wang et al.
KIDNEY INTERNATIONAL (2000)
Openings between defective endothelial cells explain tumor vessel leakiness
H Hashizume et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)
Metabolic stress and altered glucose transport - Activation of AMP-activated protein kinase as a unifying coupling mechanism
T Hayashi et al.
DIABETES (2000)